Premix blends that target complementary pathways for enhanced recovery.
Stack protocols are community-reported, not clinically established. For research purposes only. Not medical advice.
Maximum injury recovery — tendon, ligament, and muscle repair
BPC-157 250mcg + TB-500 2.5mg, subcutaneous, daily for 4–6 weeks
BPC-157 accelerates tissue repair while TB-500 promotes cell migration and new blood-vessel formation. Together they hit complementary healing pathways — commonly sold as a premix blend.

Natural growth-hormone release — recovery, body composition, sleep
Ipamorelin + CJC-1295 (Mod GRF 1-29), 1–2× daily subcutaneous
A GH-releasing peptide paired with a GH-releasing-hormone analogue to pulse endogenous GH together, with comparatively little prolactin/cortisol effect. A popular IPA/CJC blend.

Broad-spectrum recovery — tissue repair, skin/collagen, inflammation
A premix of GHK-Cu + BPC-157 + TB-500 + KPV
Combines the collagen/skin peptide (GHK-Cu), two repair/remodelling peptides (BPC-157, TB-500), and an anti-inflammatory tripeptide (KPV) in a single blend — a signature multi-healing stack.

Metabolic — weight loss and glucose control (GLP-1 / GIP)
Tirzepatide once weekly
Tirzepatide is the dual GLP-1/GIP agonist behind current gold-standard obesity therapy. Offered under a GLP-2 product line.

Next-gen metabolic — GLP-1 / GIP / glucagon triple agonist
Retatrutide once weekly
Retatrutide is a triple-agonist weight-loss candidate (Phase 3) extending the incretin class. Offered under a GLP-3 product line.
